Targeting and activation of antigen-specific B-cells by calcium phosphate nanoparticles loaded with protein antigen

Biomaterials

Volumn 35, Issue 23, 2014, Pages 6098-6105

  Temchura, Vladimir V ^a   Kozlova, Diana ^b   Sokolova, Viktoriya ^b   Überla, Klaus ^a   Epple, Matthias ^b  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

B cell activation; Calcium phosphate; Cell targeting; Nanoparticles

Indexed keywords

ANTIBODIES; ANTIGENS; CALCIUM PHOSPHATE; CELL MEMBRANES; NANOPARTICLES; SCANNING ELECTRON MICROSCOPY;

B-CELL RECEPTORS; CALCIUM PHOSPHATE NANOPARTICLES; CELL TARGETING; FUNCTIONALIZED NANOPARTICLES; HUMORAL IMMUNITY; PARTICULATE STRUCTURE; PROTEIN ANTIGENS; SURFACE EXPRESSION;

CYTOLOGY;

ANTIGEN; B LYMPHOCYTE RECEPTOR; BIOMATERIAL; CALCIUM PHOSPHATE; LYSOZYME; NANOPARTICLE; VACCINE; HEN EGG LYSOZYME; LYMPHOCYTE ANTIGEN RECEPTOR; NANOCAPSULE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CELL SURFACE; COCULTURE; CONTROLLED STUDY; CROSS LINKING; EXPERIMENTAL MODEL; EXPOSURE; HUMORAL IMMUNITY; INTERNALIZATION; LIGHT SCATTERING; MATERIAL COATING; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; TRANSGENIC MOUSE; WILD TYPE; ANIMAL; C57BL MOUSE; CELL CULTURE; CHEMISTRY; DRUG EFFECTS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; ULTRASTRUCTURE;

ANIMALS; B-LYMPHOCYTES; CALCIUM PHOSPHATES; CELLS, CULTURED; IMMUNITY, HUMORAL; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MURAMIDASE; NANOCAPSULES; RECEPTORS, ANTIGEN, B-CELL;

EID: 84900009827     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.04.010     Document Type: Article

References (30)

1. Bachmann M.F., Rohrer U.H., Kündig T.M., Bürki K., Hengartner H., Zinkernagel R.M. The influence of antigen organization on B cell responsiveness. Science 1993, 262:1448-1451.
2. Kim Y.M., Pan J.Y., Korbel G.A., Peperzak V., Boes M., Ploegh H.L. Monovalent ligation of the B cell receptor induces receptor activation but fails to promote antigen presentation. Proc Natl Acad Sci USA 2006, 103:3327-3332.
3. Storni T., Kündig T.M., Senti G., Johansen P. Immunity in response to particulate antigen-delivery systems. Adv Drug Deliv Rev 2005, 57:333-355.
4. Deml L., Speth C., Dierich M.P., Wolf H., Wagner R. Recombinant HIV-1 Pr55gag virus-like particles: potent stimulators of innate and acquired immune responses. Mol Immunol 2005, 42:259-277.
5. Sokolova V., Knuschke T., Kovtun A., Buer J., Epple M., Westendorf A.M. The use of calcium phosphate nanoparticles encapsulating toll-like receptor ligands and the antigen hemagglutinin to induce dendritic cell maturation and T cell activation. Biomaterials 2010, 31:5627-5633.
6. Akagi T., Baba M., Akashi M. Biodegradable nanoparticles as vaccine adjuvants and delivery systems: regulation of immune responses by nanoparticle-based vaccine. Adv Polym Sci 2012, 247:31-64.
7. Daftarian P., Kaifer A.E., Li W., Blomberg B.B., Frasca D., Roth F., et al. Peptide-conjugated PAMAM dendrimer as a universal DNA vaccine platform to target antigen-presenting cells. Cancer Res 2011, 71:7452-7462.
8. Mahony D., Cavallaro A.S., Stahr F., Mahony T.J., Qiao S.Z., Mitter N. Mesoporous silica nanoparticles act as a self-adjuvant for ovalbumin model antigen in mice. Small 2013, 9:3138-3146.
9. Sahdev P., Podaralla S., Kaushik R.S., Perumal O. Calcium phosphate nanoparticles for transcutaneous vaccine delivery. JBiomed Nanotechnol 2013, 9:132-141.
10. Knuschke T., Sokolova V., Rotan O., Wadwa M., Tenbusch M., Hansen W., et al. Immunization with biodegradable nanoparticles efficiently induces cellular immunity and protects against influenza virus infection. JImmunol 2013, 12:6221-6229.
11. Sokolova V.V., Radtke I., Heumann R., Epple M. Effective transfection of cells with multi-shell calcium phosphate-DNA nanoparticles. Biomaterials 2006, 27:3147-3153.
12. Sokolova V., Kovtun A., Prymak O., Meyer-Zaika W., Kubareva E.A., Romanova E.A., et al. Functionalisation of calcium phosphate nanoparticles by oligonucleotides and their application to gene silencing. JMater Chem 2007, 17:721-727.
13. Klesing J., Wiehe A., Gitter B., Gräfe S., Epple M. Positively charged calcium phosphate/polymer nanoparticles for photodynamic therapy. JMater Sci Mater Med 2010, 21:887-892.
14. Smith D.M., Simon J.K., Baker J.R.J. Applications of nanotechnology for immunology. Nat Rev Immunol 2013, 13:592-605.
15. Silva J.M., Videira M., Gaspar R., Préat V., Florindo H.F. Immune system targeting by biodegradable nanoparticles for cancer vaccines. JControl Release 2013, 168:179-199.
16. Gregory A.E., Titball R., Williamson D. Vaccine delivery using nanoparticles. Front Cell Infect Microbiol 2013, 25:1-13.
17. Dorozhkin S.V., Epple M. Biological and medical significance of calcium phosphates. Angew Chem Int Ed 2002, 41:3130-3146.
18. Sokolova V., Kozlova D., Knuschke T., Buer J., Westendorf A.M., Epple M. Mechanism of the uptake of cationic and anionic calcium phosphate nanoparticles by cells. Acta Biomater 2013, 9:7527-7535.
19. Kozlova D., Chernousova S., Knuschke T., Buer J., Westendorf A.M., Epple M. Cell targeting by antibody-functionalized calcium phosphate nanoparticles. JMater Chem 2012, 22:396-404.
20. Sokolova V., Knuschke T., Buer J., Westendorf A.M., Epple M. Quantitative determination of the composition of multi-shell calcium phosphate-oligonucleotide nanoparticles and their application for the activation of dendritic cells. Acta Biomater 2011, 7:4029-4036.
21. Oshiba A., Renz H., Yata J., Gelfand E.W. Isolation and characterization of human antigen-specific B lymphocytes. Clin Immunol Immunopathol 1994, 72:342-349.
22. Amanna I.J., Slifka M.K. Quantitation of rare memory B cell populations by two independent and complementary approaches. JImmunol Methods 2006, 317:175-185.
23. Phan T.G., Amesbury M., Gardam S., Crosbie J., Hasbold J., Hodgkin P.D., et al. Bcell receptor - independent stimuli trigger immunoglobulin (Ig) class switch recombination and production of IgG autoantibodies by anergic self-reactive B cells. JExp Med 2003, 197:845-860.
24. Gardt O., Grewe B., Tippler B.G., Überla K., Temchura V.V. HIV-derived lentiviral particles promote T-cell independent activation and differentiation of naïve cognate conventional B2-cells invitro. Vaccine 2013, 44:5088-5098.
25. Neumeier M., Hails L.A., Davis S.A., Mann S., Epple M. Synthesis of fluorescent core-shell hydroxyapatite nanoparticles. JMater Chem 2011, 21:1250-1254.
26. Malhotra S., Kovats S., Zhang W., Coggeshall K.M. Bcell antigen receptor endocytosis and antigen presentation to T cells require Vav and dynamin. JBiol Chem 2009, 284:24088-24097.
27. Ruprecht C.R., Lanzavecchia A. Toll-like receptor stimulation as a third signal required for activation of human naive B-cells. Eur J Immunol 2006, 36:810-816.
28. Nemazee D., Gavin A., Hoebe K., Beutler B. Immunology: toll-like receptors and antibody responses. Nature 2006, 441:E4.
29. Pasare C., Medzhitov R. Control of B-cell responses by toll-like receptors. Nature 2005, 438:364-368.
30. Genestier L., Taillardet M., Mondiere P., Gheit H., Bella C., Defrance T. TLR agonists selectively promote terminal plasma cell differentiation of B cell subsets specialized in thymus-independent response. JImmunol 2007, 178:7779-7786.